It has been previously shown that CXCL16 is responsible for attracting tumor-specific T cells to the irradiated tumor site [23] and is a crucial component of the successful combination of radiotherapy and anti-CTLA4 treatment in a mouse breast cancer model [24]. This evidence concerns the gene CTLA4 and neoplasm.